Literature DB >> 24109224

The Fc region of an antibody impacts the neutralization of West Nile viruses in different maturation states.

Phong D Lee1, Swati Mukherjee, Melissa A Edeling, Kimberly A Dowd, S Kyle Austin, Carolyn J Manhart, Michael S Diamond, Daved H Fremont, Theodore C Pierson.   

Abstract

Flavivirus-infected cells secrete a structurally heterogeneous population of viruses because of an inefficient virion maturation process. Flaviviruses assemble as noninfectious, immature virions composed of trimers of envelope (E) and precursor membrane (prM) protein heterodimers. Cleavage of prM is a required process during virion maturation, although this often remains incomplete for infectious virus particles. Previous work demonstrated that the efficiency of virion maturation could impact antibody neutralization through changes in the accessibility of otherwise cryptic epitopes on the virion. In this study, we show that the neutralization potency of monoclonal antibody (MAb) E33 is sensitive to the maturation state of West Nile virus (WNV), despite its recognition of an accessible epitope, the domain III lateral ridge (DIII-LR). Comprehensive epitope mapping studies with 166 E protein DIII-LR variants revealed that the functional footprint of MAb E33 on the E protein differs subtly from that of the well-characterized DIII-LR MAb E16. Remarkably, aromatic substitutions at E protein residue 306 ablated the maturation state sensitivity of E33 IgG, and the neutralization efficacy of E33 Fab fragments was not affected by changes in the virion maturation state. We propose that E33 IgG binding on mature virions orients the Fc region in a manner that impacts subsequent antibody binding to nearby sites. This Fc-mediated steric constraint is a novel mechanism by which the maturation state of a virion modulates the efficacy of the humoral immune response to flavivirus infection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24109224      PMCID: PMC3838241          DOI: 10.1128/JVI.02340-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  73 in total

1.  Influence of pr-M cleavage on the heterogeneity of extracellular dengue virus particles.

Authors:  Jiraphan Junjhon; Thomas J Edwards; Utaiwan Utaipat; Valorie D Bowman; Heather A Holdaway; Wei Zhang; Poonsook Keelapang; Chunya Puttikhunt; Rushika Perera; Paul R Chipman; Watchara Kasinrerk; Prida Malasit; Richard J Kuhn; Nopporn Sittisombut
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

2.  Characterization of dengue complex-reactive epitopes on dengue 3 virus envelope protein domain III.

Authors:  Kiyohiko Matsui; Gregory D Gromowski; Li Li; Amy J Schuh; J Ching Lee; Alan D T Barrett
Journal:  Virology       Date:  2008-12-19       Impact factor: 3.616

3.  Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody.

Authors:  Mickaël V Cherrier; Bärbel Kaufmann; Grant E Nybakken; Shee-Mei Lok; Julia T Warren; Beverly R Chen; Christopher A Nelson; Victor A Kostyuchenko; Heather A Holdaway; Paul R Chipman; Richard J Kuhn; Michael S Diamond; Michael G Rossmann; Daved H Fremont
Journal:  EMBO J       Date:  2009-08-27       Impact factor: 11.598

4.  The flavivirus precursor membrane-envelope protein complex: structure and maturation.

Authors:  Long Li; Shee-Mei Lok; I-Mei Yu; Ying Zhang; Richard J Kuhn; Jue Chen; Michael G Rossmann
Journal:  Science       Date:  2008-03-28       Impact factor: 47.728

5.  Structure of the immature dengue virus at low pH primes proteolytic maturation.

Authors:  I-Mei Yu; Wei Zhang; Heather A Holdaway; Long Li; Victor A Kostyuchenko; Paul R Chipman; Richard J Kuhn; Michael G Rossmann; Jue Chen
Journal:  Science       Date:  2008-03-28       Impact factor: 47.728

6.  Role of BC loop residues in structure, function and antigenicity of the West Nile virus envelope protein receptor-binding domain III.

Authors:  Shuliu Zhang; Evgeniy I Bovshik; Rodrigo Maillard; Gregory D Gromowski; David E Volk; Catherine H Schein; Claire Y-H Huang; David G Gorenstein; James C Lee; Alan D T Barrett; David W C Beasley
Journal:  Virology       Date:  2010-05-06       Impact factor: 3.616

7.  Characterization of dengue virus complex-specific neutralizing epitopes on envelope protein domain III of dengue 2 virus.

Authors:  Gregory D Gromowski; Nicholas D Barrett; Alan D T Barrett
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

8.  Characterization of the functional requirements of West Nile virus membrane fusion.

Authors:  Bastiaan Moesker; Izabela A Rodenhuis-Zybert; Tjarko Meijerhof; Jan Wilschut; Jolanda M Smit
Journal:  J Gen Virol       Date:  2009-10-14       Impact factor: 3.891

9.  Crystal structure of dengue virus type 1 envelope protein in the postfusion conformation and its implications for membrane fusion.

Authors:  Vinod Nayak; Moshe Dessau; Kaury Kucera; Karen Anthony; Michel Ledizet; Yorgo Modis
Journal:  J Virol       Date:  2009-02-25       Impact factor: 5.103

10.  Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization.

Authors:  Steevenson Nelson; Christiane A Jost; Qinq Xu; Jessica Ess; Julie E Martin; Theodore Oliphant; Stephen S Whitehead; Anna P Durbin; Barney S Graham; Michael S Diamond; Theodore C Pierson
Journal:  PLoS Pathog       Date:  2008-05-09       Impact factor: 6.823

View more
  15 in total

Review 1.  Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity.

Authors:  Laura A VanBlargan; Leslie Goo; Theodore C Pierson
Journal:  Microbiol Mol Biol Rev       Date:  2016-10-26       Impact factor: 11.056

2.  Combined effects of the structural heterogeneity and dynamics of flaviviruses on antibody recognition.

Authors:  Kimberly A Dowd; Swati Mukherjee; Richard J Kuhn; Theodore C Pierson
Journal:  J Virol       Date:  2014-07-30       Impact factor: 5.103

3.  Plasticity of a critical antigenic determinant in the West Nile virus NY99 envelope protein domain III.

Authors:  Jessica A Plante; Maricela Torres; Claire Y-H Huang; David W C Beasley
Journal:  Virology       Date:  2016-06-07       Impact factor: 3.616

4.  Identification of Dengue Virus Serotype 3 Specific Antigenic Sites Targeted by Neutralizing Human Antibodies.

Authors:  Ellen Young; Robert H Carnahan; Daniela V Andrade; Nurgun Kose; Rachel S Nargi; Ethan J Fritch; Jennifer E Munt; Michael P Doyle; Laura White; Thomas J Baric; Mark Stoops; Aravinda DeSilva; Longping V Tse; David R Martinez; Deanna Zhu; Stefan Metz; Marcus P Wong; Diego A Espinosa; Magelda Montoya; Scott B Biering; Soila Sukulpolvi-Petty; Guillermina Kuan; Angel Balmaseda; Michael S Diamond; Eva Harris; James E Crowe; Ralph S Baric
Journal:  Cell Host Microbe       Date:  2020-05-13       Impact factor: 21.023

5.  Immune Evasion Strategies Used by Zika Virus to Infect the Fetal Eye and Brain.

Authors:  Branden R Nelson; Justin A Roby; William B Dobyns; Lakshmi Rajagopal; Michael Gale; Kristina M Adams Waldorf
Journal:  Viral Immunol       Date:  2019-11-05       Impact factor: 2.257

Review 6.  A game of numbers: the stoichiometry of antibody-mediated neutralization of flavivirus infection.

Authors:  Theodore C Pierson; Michael S Diamond
Journal:  Prog Mol Biol Transl Sci       Date:  2014-12-01       Impact factor: 3.622

7.  A humanized monoclonal antibody neutralizes yellow fever virus strain 17D-204 in vitro but does not protect a mouse model from disease.

Authors:  Amanda E Calvert; Kandice L Dixon; Joseph Piper; Susan L Bennett; Brett A Thibodeaux; Alan D T Barrett; John T Roehrig; Carol D Blair
Journal:  Antiviral Res       Date:  2016-04-26       Impact factor: 5.970

8.  Particle conformation regulates antibody access to a conserved GII.4 norovirus blockade epitope.

Authors:  Lisa C Lindesmith; Eric F Donaldson; Martina Beltramello; Stefania Pintus; Davide Corti; Jesica Swanstrom; Kari Debbink; Taylor A Jones; Antonio Lanzavecchia; Ralph S Baric
Journal:  J Virol       Date:  2014-05-28       Impact factor: 5.103

9.  Structural basis of potent Zika-dengue virus antibody cross-neutralization.

Authors:  Giovanna Barba-Spaeth; Wanwisa Dejnirattisai; Alexander Rouvinski; Marie-Christine Vaney; Iris Medits; Arvind Sharma; Etienne Simon-Lorière; Anavaj Sakuntabhai; Van-Mai Cao-Lormeau; Ahmed Haouz; Patrick England; Karin Stiasny; Juthathip Mongkolsapaya; Franz X Heinz; Gavin R Screaton; Félix A Rey
Journal:  Nature       Date:  2016-06-23       Impact factor: 49.962

10.  The West Nile virus-like flavivirus Koutango is highly virulent in mice due to delayed viral clearance and the induction of a poor neutralizing antibody response.

Authors:  Natalie A Prow; Yin X Setoh; Rebecca M Biron; David P Sester; Kwang Sik Kim; Jody Hobson-Peters; Roy A Hall; Helle Bielefeldt-Ohmann
Journal:  J Virol       Date:  2014-06-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.